November 4, 2026 - 3:30 am

Loading weather...

DEA Fentanyl Whistleblower Raises Alarms Over Drug Trafficking Practices

Picture of Jennifer

Jennifer

Jennifer is a Staff Writer and News Correspondent at Hudson Tribune. She covers developing stories, current events, and important public-interest topics. Her work focuses on delivering clear, informative, and engaging news to readers.

A veteran federal drug enforcement officer has raised serious concerns about the U.S. Drug Enforcement Administration (DEA), alleging that investigative decisions allowed dangerous quantities of fentanyl to reach communities in New Mexico. DEA Special Agent David Howell, who remains an active agent, claims he repeatedly warned agency supervisors about the risks of allowing suspected drug shipments to proceed while investigators pursued larger trafficking networks. His allegations have intensified scrutiny of federal drug enforcement practices and their potential consequences for public safety.

DEA Fentanyl Whistleblower Questions Federal Investigation Tactics

Howell alleges that investigators used a controversial practice known as letting drugs walk. Under this approach, law enforcement officers monitor suspected drug deliveries rather than immediately intercepting them, hoping to identify higher-level traffickers and develop broader criminal cases. The agent described a 2023 investigation in Albuquerque in which officers tracked a suspect driving a white SUV with a child inside. According to Howell, agents stopped the vehicle and recovered approximately 6,000 to 7,000 fentanyl pills, along with a firearm.

He alleges that investigators subsequently faced criticism for seizing the drugs instead of allowing the suspected delivery to continue. Earlier reporting by the Associated Press documented multiple instances between 2023 and 2025 in which DEA personnel monitored substantial fentanyl shipments without immediately confiscating them. One documented delivery involved approximately 74,000 pills in Albuquerque.

Justice Department Review Intensifies as New Mexico Faces Crisis

The allegations have prompted investigations and growing political pressure. In June 2026, DEA Administrator Terrance Cole requested an independent review by the Department of Justice’s Office of the Inspector General. The Justice Department subsequently announced a broader watchdog review of federal policies and investigations involving fentanyl shipments. The examination will assess whether agents followed departmental safeguards when allowing suspected drug deliveries to proceed. New Mexico Attorney General Raúl Torrez has also pursued legal action and a criminal investigation into whether federal agents violated state law.

Meanwhile, Bernalillo County declared a state of emergency on October 14, 2026, following growing concerns about overdose deaths. County officials are seeking additional resources for treatment, recovery services and law enforcement operations. The DEA and Justice Department have not publicly established that the disputed investigative decisions caused specific overdose deaths. The independent review remains ongoing, leaving important questions about accountability and public safety unresolved.

Share It

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top